Author of the publication

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and . American journal of human genetics, 92 (4): 489–503 (2013)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 58 other author(s). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19 (11): 2859–2868 (2010)Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 169 other author(s). Human molecular genetics, 20 (16): 3304–3321 (2011)Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers, , , , , , , , , and 201 other author(s). American journal of human genetics, 92 (4): 489–503 (2013)Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk, , , , , , , , , and 252 other author(s). PLoS genetics, 9 (3): e1003212 (2013)Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2, , , , , , , , , and 172 other author(s). Breast cancer research : BCR, 13 (6): R110 (2011)Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 176 other author(s). Human mutation, 33 (4): 690–702 (2012)19p13.1 is a triple-negative-specific breast cancer susceptibility locus, , , , , , , , , and 144 other author(s). Cancer research, 72 (7): 1795–1803 (2012)Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction, , , , , , , , , and 168 other author(s). Cancer research, 70 (23): 9742–9754 (2010)Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), , , , , , , , , and 123 other author(s). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 21 (1): 134–147 (2012)Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer, , , , , , , , , and 427 other author(s). Nature genetics, 45 (4): 371-84, 384e1-2 (2013)